Temporal changes in endocardial energy metabolism following propranolol and the metabolic basis for protection against isoprenaline cardiotoxicity
- 1 April 1979
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 13 (4) , 207-214
- https://doi.org/10.1093/cvr/13.4.207
Abstract
Propranolol infusions in open-chested, anaesthetised dogs increased endocardial levels of ATP and phosphocreatine. It reduced ADP, AMP, glucose-6-phosphate and lactate in this region. Endocardial glycogen was transiently increased. Metabolic perturbations in the endocardium produced by cardiotoxic doses of isoprenaline were prevented or reduced by propranolol pre-treatment. Thus, propranolol appears to have a more selective action on endocardial versus mid-myocardial or epicardial metabolism.Keywords
This publication has 7 references indexed in Scilit:
- Inhibition of endo- and epicardial glycogenolysis by propranolol in ischemic heartsAmerican Journal of Physiology-Heart and Circulatory Physiology, 1977
- ENDOCARDIAL VIABILITY RATIO ON EFFECT OF NITROGLYCERIN AND PROPRANOLOL ON REGIONAL MYOCARDIAL BLOOD-FLOW IN INTACT CANINE HEARTS1977
- Reduced high-energy phosphate levels in rat hearts. I. Effects of alloxan diabetesAmerican Journal of Physiology-Legacy Content, 1976
- Transmural gradients in ventricular tissue metabolites produced by stopping coronary blood flow in the dog.Circulation Research, 1975
- Effect of propranolol on the metabolism and function of the rat heartJournal of Molecular and Cellular Cardiology, 1971
- Effect of Left Ventricular Hypertension, Ischemia and Vasoactive Drugs on the Myocardial Distribution of Coronary FlowCirculation Research, 1967
- STUDIES ON HEART PHOSPHOFRUCTOKINASE - ACTIVE AND INACTIVE FORMS OF ENZYME1965